{Reference Type}: Journal Article
{Title}: Alginate nanogel-embedded liposomal drug carriers facilitate drug delivery efficiency in arthritis treatment.
{Author}: Lin X;Li Y;Zhang B;Li J;Ren J;Tang Y;Wu S;Yang J;Wang Q;
{Journal}: Int J Biol Macromol
{Volume}: 273
{Issue}: 0
{Year}: 2024 Jul 10
{Factor}: 8.025
{DOI}: 10.1016/j.ijbiomac.2024.133065
{Abstract}: Despite numerous advantages of liposomes in treating rheumatoid arthritis (RA), the in vivo stability remains a critical issue. Current strategies for improving liposomal stability often compromise their original properties. Herein, we designed an alginate nanogel-embedded liposome aiming at retaining those inherent advantages while enhancing their in vivo stability. The introduction of alginate network within the liposome core can provide mechanical support and controlled drug release without affecting the surface properties. Results showed the cross-linking of alginate network within the inner core of liposomes elevated the particle rigidity to 3 times, allowing for improved stability and decreased drug leakage. Moreover, this nanogel-embedded liposome with optimized elasticity obviously facilitated cellular uptake in inflammatory macrophages. When entering blood circulation, increased rigidity altered the composition of protein corona on the particle surface, resulting in 2-fold increase in circulation time and improved drug accumulation in arthritic joints. When anti-inflammatory chlorogenic acid (CA) was encapsulated into the nanogel network, this CA-loaded nanogel-embedded liposome significantly inhibited ROS production and inflammatory response, ultimately achieved superior therapeutic outcome in arthritic rats. Results demonstrated that this nanogel-embedded liposomes can essentially retain the inherent advantages and overcome the drawbacks of liposomes, thereby improving the drug delivery efficiency.